Clover Health
@CloverHealth
Clover Health is reinventing the healthcare insurance model by integrating innovative technology into Medicare Advantage plans & applying it in an impactful way
Following a strong performance, the editors of @modrnhealthcr approached us to provide our perspective on Star Ratings. Read @andrewtoy's thoughts: modernhealthcare.com/opinion/medica…
Today we announced a new community-based pharmacy program across New Jersey in partnership with @ipcrx. The program is designed to help seniors better manage medications and stay healthier at home, supported by the local New Jersey pharmacies they know and trust. IPC’s iCare+™…
Next up: Q2 2025. Our CEO Andrew Toy will answer a selection of questions from CLOV shareholders in the week following the conclusion of our upcoming Q2 2025 earnings conference call on August 5th. We encourage current shareholders to submit questions via the Q&A form on our…
Leading up to Q1 2025 earnings, we asked Clover Health shareholders to submit questions for our CEO Andrew Toy, anything from strategy, to our business model, to how we think about the future, and our shareholders delivered. We’re honored you took the time to share such…
We reported strong 1Q25 earnings results today, and increased our full year 2025 Adjusted EBITDA and Adjusted Net Income guidance. Read more: investors.cloverhealth.com/static-files/a…
Counterpart Health’s latest data report highlights how a relationship with a PCP that uses Counterpart Assistant is associated with better health outcomes in patients with congestive heart failure → better clinical management, and fewer hospitalizations (18% lower) and…
🍀Clover Update🍀 To enhance engagement and facilitate connections with the Company's investors, our CEO Andrew Toy is planning to answer questions from CLOV shareholders regarding Clover’s business, results, strategy, and future plans. Starting today, current shareholders can…
Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance investors.cloverhealth.com/news-releases/…
News 🔔: @counterparthlth Signs Multi-Year Agreement with Southern Illinois Healthcare investors.cloverhealth.com/news-releases/…
🚀 Big news: We’ve grown Medicare Advantage membership by 27%, now covering 100,000+ lives. With ~95% enrolled in our 4-Star PPO plan, we’re focused on balancing growth, tech innovation & profitability. 💚 investors.cloverhealth.com/news-releases/… #MedicareAdvantage
Very exciting milestone for the Character Biosciences Team. After originally incubating Character Biosciences, Clover continues on the journey as a core shareholder. Under the terms of this multi-target drug discovery collaboration agreement, Character Bio has received an…
Very proud of Cheng Zhang and the Character Biosciences Team (formerly Clover Therapeutics)! medium.com/@vgaripalli/ch…
Proud to see @counterparthlth partnering with @DukeHealth's Duke Connected Care to bring cutting-edge AI to clinicians. Together, we're transforming healthcare and advancing value-based care.
🚀 Excited to announce the deployment of Counterpart Assistant with Duke Connected Care, a leader in accountable care & part of @DukeHealth. Our AI-powered platform is driving better patient outcomes & empowering physicians with actionable insights. 🌟 bit.ly/404dsXS
🍀 New Case Study 🍀 Discover how our PPO Medicare Advantage plan’s market-leading HEDIS measures were supported by innovative tech from @CounterpartHlth. 📖 Read the case study: bit.ly/4gheeHx
Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership investors.cloverhealth.com/news-and-event…
Clover Health to Report Third Quarter 2024 Financial Results on November 6 investors.cloverhealth.com/news-releases/…
Don't miss the latest from @andrewtoy linkedin.com/posts/toyand_m…
A lot of software is trying to help physicians in their practice workflow, particularly for administrative tasks. It's important, but imagine a world where you reduce all that time, but the clinical care didn’t change. That’s not Clover's definition of success. -@DavidTsayMDPhD
New Counterpart CMO talks @CloverHealth's AI capabilities bit.ly/4dLJ7lC
Back by popular demand, we've released more of the in-depth conversation between @VivekGaripalli and @andrewtoy Listen here: bit.ly/3NtlNhD
Happy AEP! ⭐⭐⭐⭐ investors.cloverhealth.com/news-releases/…
Huge congratulations to the Clover Team on achieving a 4.0 Star rating for its flagship PPO plan. While 4.0 Stars has historically been considered a standard rating for many successful MA organizations, this is a special achievement for Clover given the highly contrarian approach…